Zantac, also known by its generic name, ranitidine, is an over-the-counter heartburn and ulcer medication used by millions of Americans. Sanofi and other pharmaceutical companies recently had the drug pulled from store shelves after the U.S. Food and Drug Administration discovered it contains an ingredient that has been labeled a probable carcinogen. N-nitrosodimethylamine, also known as NDMA, has been linked to diseases such as liver and stomach cancer. The amount of NDMA discovered in the FDA’s tests were thousands of times higher than the agency’s recommended daily dose. Although drug companies were aware of this, they chose not to disclose the information to their customers.
After news of the FDA’s findings were reported, retailers such as CVS, Walgreens, Walmart, and others announced they were removing Zantac and other ranitidine products from their shelves.
Fears Nachawati is currently helping people across the country who have been hurt by this harmful drug. Our firm has extensive experience holding accountable those in the pharmaceutical industry who have repeatedly put profit above their customers’ lives. If you or a loved one developed cancer as a result of Zantac, call the experienced attorneys at Fears Nachawati for a free consultation. We can provide you with a no-obligation review of your case, explain your legal options, and help you plan a path forward. For more information, call us at (866) 705-7584, or email us at email@example.com. We’ve helped others in your position and are ready to help you, too.